Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City, New York, USA.
BMJ Open. 2019 Apr 24;9(4):e024694. doi: 10.1136/bmjopen-2018-024694.
In this era of rising healthcare costs, there is a growing interest in understanding how funding policies can be used to improve health and healthcare efficiency. Financial incentives (eg, vouchers or access to health insurance) or disincentives (eg, fines or out-of-pocket costs) affect behaviours. To date, reviews have explored the effects of financial (dis)incentives on patient health and behaviour by focusing on specific behaviours or geographical areas. The objective of this systematic review is to provide a comprehensive overview on the use of financial (dis)incentives as a means of influencing health-related behaviour and costs in randomised trials.
We will search electronic databases, clinical trial registries and websites of health economic organisations for randomised controlled trials. The initial searches, which were conducted on 13 January 2018, will be updated every 12 months until the completion of data analysis. The reference lists of included studies will be manually screened to identify additional eligible studies. Two researchers will independently review titles, abstracts and full texts to determine eligibility according to a set of predetermined inclusion criteria. Data will be extracted from included studies using a form developed and piloted by the research team. Discrepancies will be resolved through discussion with a third reviewer. Risk of bias will be assessed using the Cochrane Collaboration tool.
Ethics approval is not required since this is a review of published data. Results will be disseminated through publication in peer-reviewed journals and presentations at relevant conferences.
CRD42018097140.
在医疗成本不断上升的时代，人们越来越关注如何利用资金政策来改善健康和医疗效率。财政激励措施（例如，代金券或获得医疗保险的机会）或抑制措施（例如，罚款或自付费用）会影响行为。迄今为止，评论已经通过关注特定行为或地理区域，探讨了财政（不）激励措施对患者健康和行为的影响。本系统评价的目的是全面概述使用财政（不）激励措施作为影响随机试验中与健康相关的行为和成本的手段。
我们将搜索电子数据库、临床试验登记处和卫生经济组织的网站，以查找随机对照试验。最初的搜索于 2018 年 1 月 13 日进行，将每 12 个月更新一次，直到数据分析完成。将手动筛选纳入研究的参考文献列表，以确定其他合格的研究。两名研究人员将根据一套预定的纳入标准独立审查标题、摘要和全文，以确定是否符合条件。将使用研究小组制定和试点的表格从纳入的研究中提取数据。通过与第三名审稿人讨论解决分歧。将使用 Cochrane 协作工具评估偏倚风险。
由于这是对已发表数据的审查，因此不需要伦理批准。结果将通过在同行评议期刊上发表和在相关会议上发表来传播。
PROSPERO 注册号：CRD42018097140。
